compound glp-1 fda issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded GLP-1s: Why doctors worry

Unable to persuade his employer to commit any resources into getting a patent on it, in the end Eng filed a patent himself in May 1993

April 2026: As of April 1, 2026, there are 73 pending lawsuits in MDL 3163 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , which involves claims against Novo Nordisks Wegovy

Cell 78 , 191201 (1994)

If someone that used kratom is experiencing an overdose, call 911

Manufactured by Eli Lilly, it represents a novel class of therapy known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

It supports collagen synthesis, tendon-to-bone healing, and gut mucosal repair through pathways that are most active where the peptide is concentrated